Natural supplement shows promise for shedding body fat

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Male or female age 18-65 years. * Premenopausal female with regular menstrual cycle or post-menopausal female with cessation of menstrual cycle for a minimum of 6 months. * BMI in the range of 28.0-35.0 * Beck Depression Inventory Score less than 20. * Fluency in spoken or written English. * Willingness to be randomized to take EMIQ or placebo. * Must weigh at least 164lbs Exclusion Criteria: * Any major illness or condition that may interfere with study outcomes at the discretion of the study physician. * Diabetes Type I \& Type II, or use of any pharmacological treatment for diabetes. * Use of medications that interfere with energy metabolism * Receiving hormone therapy growth hormone, testosterone, or estrogen with the exception of hormone contraceptives. * GI diseases, conditions or medications known to influence GI absorption including active peptic ulcer disease or inflammatory bowel disease such as ulcerative colitis, Crohn's disease, celiac disease, chronic diarrhea or constipation. * Undergone gastric bypass or other bariatric weight loss procedure. * Lipid lowering medications such as: bile acid sequestrants (Cholestyramine, Colestipol, Colesevelam, etc.), cholesterol absorption inhibitors (Ezetimibe-Zetia), and fibrates (Gemfibrozil, Clofibrate, Fenofibrate, Triclor). Exceptions to this exclusion are 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase (HMG-CoA reductase or Statins). * On or planning to participate in a weight loss program. * Weight loss or weight gain greater than 10 lbs in the past 6 months. * History of eating disorders, anorexia, bulimia, or binge-eating in the past 5 years. * Participation in any regular endurance exercise: running, biking or aerobics (except walking) greater than 2.5 hours per week, or resistance training greater than once per week. * Regular use of acid lowering medications (greater than 3 times per week) such as antacids, proton pump inhibitors (PPIs), or H2 blockers. * Unstable thyroid disease. * Psychiatric disorders including schizophrenia, bipolar, major depression or psychosis. * Antidepressant medication: selective serotonin reuptake inhibitors (SSRIs), serotonin norepinephrine reuptake inhibitors (SNRIs), monoamine oxidase (MAO) inhibitors, or tricyclic antidepressants (TCAs). * Cancer of any type (except for non-melanoma skin) in the past 5 years. * Use of chemotherapeutic agents. * Pregnancy, planning to become pregnant during the study period, or breastfeeding. * Unwilling to use effective birth control during study. * History of bilateral mastectomy with nodal dissection. * Alcohol use, on average, greater than 3 servings per day, 20 servings per week (Serving size: 12oz beer, 4oz wine, 2oz hard liquor), or self-reported binge drinking. * Uncontrolled hypertension (HTN) determined at the discretion of the study MD or registered nurse (RN). HTN medications allowed in the study: angiotensin converting enzyme (ACE) inhibitors, calcium channel blockers, and diuretics. * Medications for chronic obstructive pulmonary disease (COPD) or kidney disease. * α-adrenergic or β-adrenergic blockers (oral or ocular) and diuretics. * Renal or chronic kidney disease due to any condition, renovascular disease, or dialysis. * Chronic liver disease such as hepatitis B, hepatitis C, or cirrhosis. * Cardiovascular disease including: myocardial infarction, cerebrovascular disease (CVA), coronary artery bypass graft, stenosis greater than 50%, angina, coronary artery disease (CAD), congestive heart failure (CHF),peripheral vascular disease (PVD) or dysautonomia. * History of autoimmune diseases such as rheumatoid arthritis, lupus, multiple sclerosis, vitiligo, or psoriasis. * HIV or AIDS based on self-report. * Steroid use with the exception of over-the-counter topical and nasal steroids such as Flonase. * Allergy medication or regular antihistamine use. * Seizure disorders. Acceptable if managed with medication and free of seizure activity for 5 years. * Smoking or the use of nicotine replacement products in the past 6 months. * Use of dietary supplements containing vitamins (except Calcium and Vitamin D), minerals, herbal or plant-based preparations, fish oil or homeopathic remedies during study participation unless willing to discontinue prior to enrollment. * Current participation in another research study. * Non-English speaking. * No social security number. * Participation in another research study.